HYDROXY-SPHINGOMYELIN 22:1 AS BIOMARKER FOR HEALTHY AGEING
    10.
    发明申请
    HYDROXY-SPHINGOMYELIN 22:1 AS BIOMARKER FOR HEALTHY AGEING 审中-公开
    羟脯氨酸22:1作为生物标记用于健康衰老

    公开(公告)号:WO2013139584A1

    公开(公告)日:2013-09-26

    申请号:PCT/EP2013/054335

    申请日:2013-03-05

    Applicant: NESTEC S.A.

    Abstract: Using NMR/MS based metabonomics and targeted lipidomics approaches the inventors have explored the metabolic phenotypes of aging and longevity in a cohort compromising centenarians, elderly and young adults. The inventors have identified biomarkers for a reduced risk of developing ageing related chronic inflammatory disorders and propose a method of diagnosing a lifestyle that allows delaying and/or avoiding ageing related chronic inflammatory disorders using hydroxy- sphingomyelin SM-OH-22:1as biomarker.

    Abstract translation: 使用基于NMR / MS的代谢组学和靶向脂质组学方法,发明人已经探索了老年人和年轻成年人的老龄化和长寿的代谢表型。 本发明人已经鉴定出降低发展与衰老有关的慢性炎症性疾病风险的生物标志物,并提出了一种诊断生活方式的方法,该方法允许使用羟基鞘磷脂SM-OH-22:1作为生物标志物来延缓和/或避免老化相关的慢性炎症性疾病。

Patent Agency Ranking